EODData

OSL, CONTX: ContextVision AB

13 Nov 2025
LAST:

3.780

CHANGE:
 0.29
OPEN:
3.640
HIGH:
3.780
ASK:
0.000
VOLUME:
27.0K
CHG(%):
6.55
PREV:
4.430
LOW:
3.640
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
13 Nov 253.6403.7803.6403.78027.0K
12 Nov 253.8503.8503.7203.80025.7K
11 Nov 253.7103.7603.7003.7605.1K
10 Nov 253.7603.7603.6803.70013.8K
07 Nov 253.8903.9003.7303.84031.2K
03 Nov 254.3304.4304.2804.33057.1K
31 Oct 254.3304.3304.3304.33030.4K
30 Oct 254.3404.4304.3004.30044.5K
29 Oct 254.4704.4704.4004.43037.6K
27 Oct 254.4904.4904.4204.43011.4K

COMPANY PROFILE

Name:ContextVision AB
About:ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. The company offers image quality solutions for ultrasound, as well as its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image quality of 3D ultrasound; and Rivent Mobile, a 2D image enhancement for handheld devices for diagnostics in various fields, including radiology, cardiology, women's health, veterinary medicine, and point of-care applications. It also provides Altumira platform, which features scatter correction and improves radiography by enabling radiation dose reduction while enhancing image quality, such as Altumira for static applications; and Altumira Plus for dynamic applications. In addition, the company offers image quality solutions for MRI including GOPView MRI2Plus for the requirements of each application, sequence type, and protocol; and implementation projects, software updates, and upgrades and product support services. It has a strategic clinical development partnership with the University of Washington School of Medicine for collecting medical imaging data to identify a multiparametric biomarker for the screening and staging of the liver disease MASLD; and research partnership with AMRA Medical to develop AI-powered, organ-specific imaging solutions that enable MASLD screening and physiological quantification. ContextVision AB (publ) was incorporated in 1989 and is headquartered in Stockholm, Sweden.
Sector:Healthcare
Address:Gamla Brogatan 26, Stockholm, Sweden, 111 20
Website:https://www.contextvision.com
ISIN:SE0014731154
LEI:549300DGJB24U1VKHC98

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:33.46 
Forward P/E:14.03 
PEG Ratio:-0.33 
Price to Sales:2.85 
Price to Book:3.68 
Profit Margin:0.08 
Operating Margin:0.02 
Return on Assets:0.01 
Return on Equity:0.10 
Revenue:123.32M 
EBITDA:42.89M 
Shares:76.13M 
Market Cap:287.76M 

TECHNICAL INDICATORS

MA5:4.4718.3%
MA10:4.5119.3%
MA20:4.6322.6%
MA50:4.6924.0%
MA100:5.0333.1%
MA200:5.0934.6%
STO9:95.65 
STO14:84.62 
RSI14:46.26
WPR14:-15.38 
MTM14:-0.08
ROC14:-0.02 
ATR:0.21 
Week High:4.8428.0%
Week Low:3.643.8%
Month High:4.8428.0%
Month Low:3.6434.6%
Year High:6.6074.6%
Year Low:3.643.8%
Volatility:2.30 

RECENT SPLITS

Date Ratio
19 Aug 202010-1

RECENT DIVIDENDS

Date Amount
02 Nov 2023$0.16
08 May 2023$0.16
06 Jun 2008$0.01